Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mutation Identified Leading to Mitochondrial Dysfunction and Heart Failure

By LabMedica International staff writers
Posted on 07 Jun 2011
A mutation in the gene that encodes for a protein thought to protect cells from stress-induced mitochondrial dysfunction has been linked to the chain of molecular events leading to heart failure.

Mutations in the PTEN-inducible kinase 1 (PINK1) gene cause one form of autosomal recessive early-onset Parkinson's disease. More...
The mutations cause neurons to be more susceptible to reactive oxygen species (ROS) and more likely to undergo apoptosis.

As oxidative stress with associated mitochondrial dysfunction leads to cardiac dysfunction and heart failure (HF), investigators at the Peter Munk Cardiac Center (Toronto, Canada) elected to examine the role of the PINK1 gene in this process.

After observing that PINK1 protein levels were markedly reduced in end-stage human HF and that PINK1 localized exclusively to the mitochondria, the investigators genetically engineered a line of mice to lack the gene for PINK1.

They reported in the May 23, 2011, online edition of the journal Proceedings of the [US] National Academy of Sciences that PINK1 "knockout" mice developed left ventricular dysfunction and evidence of pathological cardiac hypertrophy as early as two months of age. The knockout mice had greater levels of oxidative stress and impaired mitochondrial function. There were also higher degrees of fibrosis, cardiomyocyte apoptosis, and a reciprocal reduction in capillary density.

"Our research suggests that PINK1 is an important switch that sets off a cascade of events affecting heart cell metabolism," said first author Dr. Phyllis Billia, a heart failure specialist at the Peter Munk Cardiac Center. "This could be one of the inciting events in the development of heart failure. We need to learn more about PINK1 and the other proteins it interacts with at the subcellular level, but if we have identified the inciting event that causes the chain of events leading to failure, research and drug development strategies should be focused in this new area of science."

Related Links:
Peter Munk Cardiac Center


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.